Re: New Zenith poster

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Zenith poster

in response to

New Zenith poster

GeorgeParros

posted on Dec 11, 2020 10:43AM

Phase 2 portion of the trial, ZEN-3694 + Talazoparib (TALB), is ongoing.

What's it going to take to IPO Zenith, once and for all?

Koo

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply